The Mountain View, CA-based company now has FDA clearance for its KardiaMobile ECG to detect BradyCardia and TachyCardia.
FDA’s approval of the Marlborough, MA-based company’s Lotus Edge Valve could represent a paradigm shift in the transcatheter aortic valve replacement market.
Yokneam, Israel-based Rapid Medical has raised $20 million in a series C round and will use the proceeds to help complete its IDE study.
FDA’s approval of BAROnova’s TransPyloric Shuttle device comes during a time of significant shifts and changes in the obesity treatment market.
Large retailers are planting their flags in healthcare with Amazon and Best Buy leading the charge to get into the market.
NeuroSigma’s Monarch eTNS might be the first device to treat ADHD, but it is one of a growing number of technologies that occupy the burgeoning bioelectronic medicine space.
The Sunnyvale, CA-based company has long been the top dog in surgical robotics but increased competition is right around the corner for the firm.
Neovasc said it had resolved the three claims of correction of patent inventorship made by Irvine, CA-based Edwards Lifesciences.
The Abbott Park, IL-based has had a solid foundation of success dating back to the closure of the St. Jude Medical acquisition.
Results from the prospective, randomized, controlled, multi-surgeon clinical trial were published in Ophthalmology Glaucoma.
Johnson & Johnson’s earnings might have been down 14% when compared to last year, but the New Brunswick, NJ-based company was still able to beat analysts’ expectations.